Arsenic agent shuts down two hard-to-treat cancers in animal experiments
Links shared publicly online about this topic.
- 633total visits
Arsenic agent shuts down two hard-to-treat cancers in animal experiments
Researchers have found that an arsenic-based agent already FDA-approved for a type of leukemia may be helpful in another hard-to-treat cancer, Ewing's Sarcoma (ES). The research, based on animal studies, also suggests the drug might be beneficial in treating medulloblastoma, a highly malignant pediatric brain cancer.
View full resource at sciencedaily.com
Tags: Cancer, Bone Cancer, Ewing Family of Tumors, Brain Tumor, Leukemia, Drug, Nature
Most Recently Shared on December 24, 2010 at 2:17 am By:
Arsenic agent shuts down two hard-to-treat cancers in animal experiments http://bit.ly/gY4hCk
Arsenic agent shuts down two hard-to-treat cancers in animal experiments
physorg.com — “Researchers at the Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center, have found that an arsenic-based agent already FDA-approved for a type of leukemia may be helpful in another hard-to-treat cancer, Ewing's Sarcoma (ES). The research, based on animal studies, ...” View full resource at physorg.com
Most Recently Shared on December 22, 2010 at 6:48 pm By:
Arsenic agent shuts down two hard-to-treat cancers in animal experiments http://bit.ly/dSMtvf
Advertisement
